Racial and ethnic disparities in United States stroke care vary by intervention type at the national and state levels.
Tenecteplase improved functional outcomes without added safety risk in selected basilar artery occlusion stroke treated up to 24 hours after onset in the TRACE-5 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback